Literature DB >> 1346094

Multidrug resistance (MDR 1) in leukemia: is it time to test?

D A Haber.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1346094

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  6 in total

Review 1.  Classical multidrug resistance in acute myeloid leukaemia.

Authors:  E Paietta
Journal:  Med Oncol       Date:  1997-03       Impact factor: 3.064

Review 2.  Multidrug resistance in cancer chemotherapy.

Authors:  N H Patel; M L Rothenberg
Journal:  Invest New Drugs       Date:  1994       Impact factor: 3.850

3.  Multidrug resistance 1 gene expression and AgNOR in childhood acute leukemias.

Authors:  S Balamurugan; D Sugapriya; P Shanthi; V Thilaka; S Venkatadesilalu; V Pushpa; M Madhavan
Journal:  Indian J Hematol Blood Transfus       Date:  2008-03-19       Impact factor: 0.900

4.  PCR-determined expression of the MDR1 gene in chronic lymphocytic leukemia.

Authors:  C F Rochlitz; E de Kant; A Neubauer; I Heide; R Böhmer; J Oertel; D Huhn; R Herrmann
Journal:  Ann Hematol       Date:  1992-12       Impact factor: 3.673

5.  Determination of the relationship between doxorubicin resistance and Wnt signaling pathway in HeLa and K562 cell lines.

Authors:  Pelin Mutlu; Serap Yalçin Azarkan; Negar Taghavi Pourianazar; Meral Yücel; Ufuk Gündüz
Journal:  EXCLI J       Date:  2018-05-02       Impact factor: 4.068

6.  Treatment of adult T-cell leukaemia-lymphoma with irinotecan hydrochloride (CPT-11). CPT-11 Study Group on Hematological Malignancy.

Authors:  H Tsuda; K Takatsuki; R Ohno; T Masaoka; K Okada; S Shirakawa; Y Ohashi; K Ota
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.